tiprankstipranks
Savencia SA (FR:SAVE)
:SAVE

Savencia (SAVE) AI Stock Analysis

4 Followers

Top Page

FR:SAVE

Savencia

(SAVE)

Select Model
Select Model
Select Model
Neutral 56 (OpenAI - 5.2)
Rating:56Neutral
Price Target:
€61.00
▼(-1.61% Downside)
Action:DowngradedDate:03/20/26
Overall score is driven mainly by financial performance: 2025 showed weaker revenue, margin compression, and notably poorer free-cash-flow conversion, which limits flexibility. Technicals are slightly negative with weak momentum and price below the 200-day average, while valuation (moderate P/E and ~2.7% yield) offers some offsetting support.
Positive Factors
Market position & distribution
Savencia’s entrenched position as a global dairy leader and diversified distribution (retail, foodservice, industrial) creates durable revenue channels. Broad customer mix and partnerships with major retailers support resilience to single-channel shocks and enable long-term scale and shelf presence.
Negative Factors
2025 revenue decline
A YoY revenue drop in 2025 interrupts prior multi-year growth and signals potential demand softness or competitive pressure. Persistent or recurring revenue declines reduce operating leverage and complicate investment planning, making recovery reliant on execution or market rebound.
Read all positive and negative factors
Positive Factors
Negative Factors
Market position & distribution
Savencia’s entrenched position as a global dairy leader and diversified distribution (retail, foodservice, industrial) creates durable revenue channels. Broad customer mix and partnerships with major retailers support resilience to single-channel shocks and enable long-term scale and shelf presence.
Read all positive factors

Savencia (SAVE) vs. iShares MSCI France ETF (EWQ)

Savencia Business Overview & Revenue Model

Company Description
Savencia SA produces dairy products in France and internationally. It offers cheese; butters and creams for the retail market and catering professionals; and dairy ingredients for the food, nutrition, and healthcare industries. The company was for...
How the Company Makes Money
Savencia generates revenue primarily through the sale of its dairy products, which are distributed to various channels including supermarkets, restaurants, and food manufacturers. Key revenue streams include retail sales of branded and private lab...

Savencia Financial Statement Overview

Summary
Results indicate stable scale but weakening near-term fundamentals: 2025 revenue declined (-2.8% YoY), EBIT/EBITDA margins compressed, and net margin remains very thin (~1.1%). Leverage is manageable (debt-to-equity ~0.74) but returns are modest (ROE ~4.4%), while cash conversion weakened materially with lower operating cash flow and sharply reduced free cash flow (FCF ~19% of net income).
Income Statement
56
Neutral
Balance Sheet
62
Positive
Cash Flow
50
Neutral
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue6.96B7.14B6.79B6.55B5.61B
Gross Profit2.36B2.41B2.21B279.49M291.00M
EBITDA405.54M464.55M412.74M373.25M372.31M
Net Income74.70M106.97M96.48M68.05M82.94M
Balance Sheet
Total Assets4.88B4.95B4.65B4.58B4.32B
Cash, Cash Equivalents and Short-Term Investments684.84M753.34M636.14M572.63M572.62M
Total Debt1.24B1.21B1.19B1.08B1.09B
Total Liabilities2.94B2.96B2.83B2.76B2.62B
Stockholders Equity1.68B1.74B1.58B1.59B1.48B
Cash Flow
Free Cash Flow59.45M138.77M81.70M66.65M72.36M
Operating Cash Flow313.85M386.89M260.61M255.05M301.79M
Investing Cash Flow-427.70M-243.88M-236.29M-196.95M-230.59M
Financing Cash Flow-108.28M-10.74M28.18M-59.01M-120.07M

Savencia Technical Analysis

Technical Analysis Sentiment
Negative
Last Price62.00
Price Trends
50DMA
59.87
Negative
100DMA
59.55
Negative
200DMA
61.23
Negative
Market Momentum
MACD
-0.03
Negative
RSI
48.09
Neutral
STOCH
62.30
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:SAVE, the sentiment is Negative. The current price of 62 is above the 20-day moving average (MA) of 59.40, above the 50-day MA of 59.87, and above the 200-day MA of 61.23, indicating a neutral trend. The MACD of -0.03 indicates Negative momentum. The RSI at 48.09 is Neutral, neither overbought nor oversold. The STOCH value of 62.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:SAVE.

Savencia Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
€3.48B5.6911.24%1.76%514.19%-7.82%
64
Neutral
€44.68B27.0711.27%2.80%0.54%83.09%
56
Neutral
€814.67M5.295.22%2.73%5.30%-14.66%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
55
Neutral
€92.77M4.645.18%0.17%-97.54%
54
Neutral
€277.19M1.523.16%1.98%-7.08%90.42%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FR:SAVE
Savencia
59.40
2.48
4.36%
FR:BON
Bonduelle
8.62
1.65
23.69%
FR:BN
DANONE SA
69.26
1.49
2.20%
FR:ALFLE
Fleury Michon
22.20
0.63
2.90%
FR:LOUP
Societe LDC Societe Anonyme
98.70
28.00
39.61%
FR:SABE
Saint Jean Groupe SA
20.00
0.00
0.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 20, 2026